Delayed diagnosis of fetal and neonatal alloimmune thrombocytopenia: A cause of perinatal mortality and morbidity

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 119, Issue 13, 2012, Pages 1612-1616

  Madani, K ^a   Kamphuis, M M ^a   Lopriore, E ^a   Porcelijn, L ^b   Oepkes, D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sanquin Diagnostiek   (Netherlands)

Author keywords

Delayed diagnosis; fetal and neonatal alloimmune thrombocytopenia; intracranial haemorrhage; pregnancy

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; BIRTH INJURY; BRAIN HEMORRHAGE; CLINICAL ARTICLE; DELAYED DIAGNOSIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN SYNDROME; DYSMATURITY; FEMALE; HUMAN; INFANT; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; PERINATAL MORBIDITY; PERINATAL MORTALITY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

COHORT STUDIES; DELAYED DIAGNOSIS; DIAGNOSTIC ERRORS; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INTRACRANIAL HEMORRHAGES; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); PREGNANCY; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84869869788     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2012.03503.x     Document Type: Article

References (16)

1. Roberts I, Murray NA,. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed 2003; 88: F359-64. (Pubitemid 37094251)
2. Van den Akker ESA, Oepkes D,. Fetal and neonatal thrombocytopenia. Best Pract Res Clin Obstet Gynaecol 2008; 22: 3-14.
3. Williamson LM, Hacket G, Rennie J, Palmer CR, Maciver C, Hadfield R, et al., The natural history of fetomaternal alloimmunization to the platelet specific antigen HPA-1a (PIAI, Zwa) as determined by antenatal screening. Blood 1998; 92: 2280-7. (Pubitemid 28452968)
4. Turner ML, Bessos H, Fagge T, Harkness M, Rentoul F, Seymour J, et al., Prospective epidemiologic study of the outcome and costeffectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005; 45: 1945-56. (Pubitemid 43971423)
5. Knight M, Pierce M, Allen D, Kurinczuk JJ, Spark P, Roberts DJ, et al., The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources. Br J Haematol 2011; 152: 460-8.
6. Muller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989; I: 363-6. (Pubitemid 19103082)
7. Spencer JA, Burrows RF,. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001; 41: 45-55. (Pubitemid 32201293)
8. Kamphuis MM, Paridaans N, Porcelijn L, De Haas M, van der Schoot C, Brand A, et al., Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: a systemic review. BJOG 2010; 117: 1335-43.
9. Sharif U, Kuban K,. Prenatal intracranial hemorrhage and neurological complications in alloimmune thrombocytopenia. J Child Neurol 2001; 16: 838-42. (Pubitemid 33150420)
10. Bussel JB, Zabusky MR, Berkowitz RL, McFarland JG,. Fetal alloimmune thrombocytopenia. N Engl J Med 1997; 337: 22-6. (Pubitemid 27290843)
11. Radder CM, Brand A, Kanhai HH,. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox Sang 2003; 84: 318-25. (Pubitemid 36702338)
12. Van den Akker ESA, Oepkes D, Lopriore E, Brand A, Kanhai HHH,. Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective. BJOG 2007; 114: 469-73. (Pubitemid 46393288)
13. Tiller H, Killie MK, Skogen B, Oian P, Husebekk A,. Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme. BJOG 2009; 116: 594-8.
14. Durand-Zaleski I, Schlegel N, Blum-Boisgard C, Uzan S, Dreyfus M, Kaplan C,. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Am J Perinatol 1996; 13: 423-31. (Pubitemid 26425206)
15. Kjedsen-Kragh J, Husebekk A, Kjaer Killie M, Skogen B,. Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health program? Transfus Apher Sci 2008; 38: 183-8.
16. Husebekk A, Killie MK, Kjeldsen-Kragh J, Skogen B,. Is it time to implement HPA-1 screening in pregnancy? Curr Opin Hematol 2009; 16: 497-502.